The REACH Regulation requires companies registering the same substance to share data and to jointly submit their registration dossier.

For phase-in substances, all existing and potential registrants that have preregistered the same substance are part of a Substance Information Exchange Forum (SIEF) that aims to:

Facilitate the exchange of information on available data between co-registrant.

Agree on classification and labelling where there is a difference between co-registrants.

Main benefits of being part of a SIEF:

Increase knowledge on your substance.

Reduce costs of registration for everyone.

Avoid duplication of animal tests.

Please find attached the substance description Frit Consortium has prepared for the substance covered by this Consortium.

For any other additional information, please do not hesitate contacting Frit Consortium.